期刊文献+

肺血栓栓塞症合并冠心病患者疾病特点及临床干预的初步研究 被引量:7

Clinical Characteristics and Intervention of Pulmonary Thromboembolism Patients with Coronary Atherosclerotic Heart Disease
下载PDF
导出
摘要 目的调查住院肺血栓栓塞症(pulmonary thromboembolism,PTE)患者合并冠心病(coronary heartdisease,CHD)的发病率,研究合并CHD对于PTE患者病情严重程度的影响,同时比较临床干预的差异。方法分析了48例合并CHD的住院PTE患者的一般情况,吸烟指数,栓塞面积,是否合并高血压和下肢深静脉血栓(deep ve-nous thrombosis,DVT),动脉血气分析结果,心肌坏死标记物和所接受的临床干预措施,并与对照组30例不合并CHD的PTE患者进行比较。结果 15.3%的住院PTE患者合并CHD,合并CHD的住院PTE患者静息时未吸氧情况下动脉血氧分压(PaO2)低于未合并CHD的PTE患者,差异有统计学意义[(73.2±8.6)mm Hg vs.(78.6±6.1)mm Hg,P=0.015];栓塞累计肺段数两组相比,合并CHD的PTE患者累及肺段多于不合并CHD的患者,差异有统计学意义[(7.1±3.4)个vs.(5.1±3.2)个,P=0.029];临床干预方面,两组均采用低分子肝素序贯华法林和(或)溶栓治疗,合并CHD的PTE患者在此基础上应用抗血小板药物治疗。结论住院PTE患者合并CHD的发病率较高,合并CHD的PTE患者肺栓塞病情较重,临床上需要采取以低分子肝素序贯华法林和抗血小板药物为主的综合治疗。 Objective To determine the prevalence of coronary atherosclerotic heart disease(CHD) in hospitalized pulmonary thromboembolism(PTE) patients and to examine its impact on the severity and management of the disease among patients with PTE. Methods Data including general information,cigarette smoking index,thromboembolism area,complication with hypertension and deep venous thrombosis(DVT) of 48 PTE patients with complicated CHD were analyzed and compared with those of 30 PTE patients without CHD. Results CHD was observed in 15.3% of the PTE patients.PaO2 values[(73.2±8.6) mm Hg vs.(78.6±6.1) mm Hg,P=0.015] and number of affected lung segments [(7.1±3.4) vs.(5.1±3.2),P=0.029] in PTE patients with complicated CHD were higher than in PTE patients without CHD.All patients received low-molecular-weight heparin followed by warfarin therapy and/or thrombolysis treatment.Anti-platelet drug treatment was also used in PTE patients with CHD. Conclusion Prevalence of CHD in patients diagnosed with PTE is high.PTE patients with CHD show more serious conditions than their counterparts without CHD.Treatments including low-molecular-weight heparin,long-term warfarin and anti-platelet drugs therapy should be used in these patients.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第31期3577-3579,共3页 Chinese General Practice
关键词 肺血栓栓塞症 冠心病 疾病特征 Pulmonary thromboembolism Coronary heart disease Disease attributes
  • 相关文献

参考文献16

二级参考文献16

共引文献2119

同被引文献36

  • 1王辉,李东旺,李成学,王波涛.冠心病合并肺栓塞4例临床分析[J].现代诊断与治疗,2012,23(5):507-508. 被引量:2
  • 2Laporte S,Mismetti P,Decousus H,et al.Clinical predictorsfor fatal pulmonary embolism in 15520 patients with venous throm-boembolism:findings from the Registro Informatizado de la Enfer-medad TromEmbolica venosa(RIETE)Registry[J].Circulation,2008,117(9):1711. 被引量:1
  • 3Wakai AP.Myocardial infarction(ST-elevation)[J].ClinEvid,2009,29(2):202. 被引量:1
  • 4Kauffmann QR.Timing is crucial in acute myocardial in-farction[J].Rev Med Chil,2008,136(6):1095. 被引量:1
  • 5Urokinase puimonary embolism trial.Phase1results:acoop-erative study[J].JAMA,1970,214(25):2163. 被引量:1
  • 6Goidhaber SZ,Haire WD,Feldstein ML,et al.Alteplaseversus heparin in acute pulmonary embolism:randomized trial as-sessing right-ventricular function and pulmonary perfusion[J].Lancet,1993,341(5):507. 被引量:1
  • 7Goldhaber SZ,Kessler CM,Heit J,et al.Randomised con-trolled trial of recombinant tissue plasminogen activator versus uro-kinase in the tretment of acute pulmonary embolism[J].Lancet,1988,2(3):293. 被引量:1
  • 8Goldhaber SZ,Kessler CM,Heit JA,et al.Recombinant tis-suetype plasminogen activator versus a novel dosing regimen ofurkinase in acute pulmonary embolism:a randomized comtrolledmulticenter trial[J].J Am Coll Cardiol,1992,20(1):24. 被引量:1
  • 9Hirsh J,Guyatt G,Albers GW,et al.Antithrombotic andthrombolytic therapy[J].Chest,2008,133(S):S110. 被引量:1
  • 10邹慕蔚.2例心肌梗死后合并肺栓塞病人的观察和护理[J].中国医药导报,2007,4(12Z):86-86. 被引量:2

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部